TITLE

Even more suicide attempts in clinical trials with paroxetine randomised against placebo

AUTHOR(S)
Aursnes, Ivar; Tvete, Ingunn Fride; Gaasemyr, Jorund; Natvig, Bent
PUB. DATE
January 2006
SOURCE
BMC Psychiatry;2006, Vol. 6, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Following our previous publication we have received critical comments to our conclusions as well as new data that are strengthening our findings. Results: With the new data, 11 suicide attempts among patients on paroxetine against 1 among patients on placebo, we found with a Bayesian technique that the posterior probability that medication with paroxetine is associated with an increased intensity per year of a suicide attempt is from 0.98 to 0.99, depending on the prior. We found that the comment to our article by GSK representatives contained errors, misunderstanding and unwillingness to accept Bayesian principles in the analysis of clinical trials. Conclusion: We were in our previous publication, with preliminary data and a Bayesian approach, able to raise a concern that suicide attempts might be connected with the use of paroxetine. This suspicion has now been confirmed.
ACCESSION #
29323781

 

Related Articles

  • Varenicline as a Cause of Suicidal Outcomes. Hughes, John R. // Nicotine & Tobacco Research;Jan2016, Vol. 18 Issue 1, p2 

    Objective: Postmarketing analyses and case reports have associated varenicline use with suicidal behaviors. This article reviews postmarketing analyses, case reports, clinical trials, uncontrolled observational studies, controlled observational studies, and studies in smokers with...

  • Are Selective Serotonin Reuptake Inhibitors a Risk Factor for Adolescent Suicide? Healy, David // Canadian Journal of Psychiatry;Feb2009, Vol. 54 Issue 2, p69 

    The article presents a debate concerning the association of Selective Serotonin Re-uptake Inhibitors in adolescent suicide. It notes that the argument from the national suicide rates excludes data from the 1960s and 1970s when the national suicide rates climbed, even the time prescriptions of...

  • A Black-Box Warning for Antidepressants in Children?  // New England Journal of Medicine;10/14/2004, Vol. 351 Issue 16, p1595 

    Presents an opinion on black-box warnings on antidepressants for children. Author's participation in a committee assigned to consider the warnings; Best evidence which came from an FDA analysis of randomized trials showed the suicidality among children on antidepressants was twice that in the...

  • A Black-Box Warning for Antidepressants in Children? Newman, Thomas B. // New England Journal of Medicine;10/14/2004, Vol. 351 Issue 16, p1595 

    Presents an opinion on black-box warnings on antidepressants for children. Author's participation in a committee assigned to consider the warnings; Best evidence which came from an FDA analysis of randomized trials showed the suicidality among children on antidepressants was twice that in the...

  • Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. Barbui, Corrado; Furukawa, Toshiaki A.; Cipriani, Andrea // CMAJ: Canadian Medical Association Journal;1/29/2008, Vol. 178 Issue 3, p296 

    Background: Concern has been raised about the efficacy of antidepressant therapy for major depression in adults. We undertook a systematic review of published and unpublished clinical trial data to determine the effectiveness and acceptability of paroxetine. Methods: We searched the Cochrane...

  • Withholding Proven Treatment in Clinical Research. Huston, Patricia; Peterson, Robert // New England Journal of Medicine;9/20/2001, Vol. 345 Issue 12, p912 

    Editorial. Discusses the ethics of placebo-controlled clinical trials. Role of the Declaration of Helsinki; Need for scientific and ethical justification of the use of placebos.

  • Saving and Empowering Young Lives in Europe (SEYLE): a randomized controlled trial. Wasserman, Danuta; Carli, Vladimir; Wasserman, Camilla; Apter, Alan; Balazs, Judit; Bobes, Julia; Bracale, Renata; Brunner, Romuald; Bursztein-Lipsicas, Cendrine; Corcoran, Paul; Cosman, Doina; Durkee, Tony; Feldman, Dana; Gadoros, Julia; Guillemin, Francis; Haring, Christian; Kahn, Jean-Pierre; Kaess, Michael; Keeley, Helen; Marusic, Dragan // BMC Public Health;2010, Vol. 10, p192 

    Background: There have been only a few reports illustrating the moderate effectiveness of suicide-preventive interventions in reducing suicidal behavior, and, in most of those studies, the target populations were primarily adults, whereas few focused on adolescents. Essentially, there have been...

  • Antidepressants: suicidality risk is 'strongly' age-related.  // Reactions Weekly;8/22/2009, Issue 1266, p4 

    The article discusses research on the risk of suicidality in clinical trials of antidepressants in adults. It references a study by M. Stone and colleagues, published in the August 2009 issue of the "British Medical Journal." The study found that risk of suicidal behavior with antidepressants...

  • March update: Research news.  // Update;3/17/2005, Vol. 70 Issue 3, p8 

    This article presents information about research related to various diseases. Suicide risk is the same in adults taking either tricyclics or SSRIs. Canadian researchers carried out a systematic review of published trials comparing SSRIs with either placebo or other active treatments. They found...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics